Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1
- PMID: 31504248
- DOI: 10.1093/cvr/cvz230
Oxidized low-density lipoproteins induce tissue factor expression in T-lymphocytes via activation of lectin-like oxidized low-density lipoprotein receptor-1
Abstract
Aims: T-lymphocytes plays an important role in the pathophysiology of acute coronary syndromes. T-cell activation in vitro by pro-inflammatory cytokines may lead to functional tissue factor (TF) expression, indicating a possible contribution of immunity to thrombosis. Oxidized low-density lipoproteins (oxLDLs) are found abundantly in atherosclerotic plaques. We aimed at evaluating the effects of oxLDLs on TF expression in T cells and the role of the lectin-like oxidized low-density lipoprotein receptor-1 (LOX-1).
Methods and results: CD3+ cells were isolated from healthy volunteers. Gene, protein, and surface expression of TF, as well as of LOX-1, were assessed at different time-points after oxLDL stimulation. To determine whether oxLDL-induced TF was LOX-1 dependent, T cells were pre-incubated with an LOX-1 inhibiting peptide (L-RBP) or with an anti-LOX-1 blocking antibody. To exclude that TF expression was mediated by reactive oxygen species (ROS) generation, oxLDL-stimulated T cells were pre-incubated with superoxide dismutase + catalase or with 4-Hydroxy-2,2,6,6-tetramethylpiperidine-1-oxyl (Tempol), an intracellular free radical scavenger. Finally, to determine if the observed findings in vitro may have a biological relevance, the presence of CD3+/TF+/LOX-1+ cells was evaluated by immunofluorescence in human carotid atherosclerotic lesions. oxLDLs induced functionally active TF expression in T cells in a dose- and time-dependent manner, independently on ROS generation. No effect was observed in native LDL-treated T cells. LOX-1 expression was also induced by oxLDLs in a time- and dose-dependent manner. Pre-incubation with L-RBP or anti-LOX-1 antibody almost completely inhibited oxLDL-mediated TF expression. Interestingly, human carotid plaques showed significant infiltration of CD3+ cells (mainly CD8+ cells), some of which were positive for both TF and LOX-1.
Conclusion: oxLDLs induce functional TF expression in T-lymphocytes in vitro via interaction of oxLDLs with LOX-1. Human carotid atherosclerotic plaques contain CD3+/CD8+cells that express both TF and LOX-1, indicating that also in patients these mechanisms may play an important role.
Keywords: Atherosclerosis; Inflammation; Lipoproteins; T-lymphocyte; Tissue factor.
Published on behalf of the European Society of Cardiology. All rights reserved. © The Author(s) 2019. For permissions, please email: journals.permissions@oup.com.
Similar articles
-
Ellagic acid inhibits oxidized LDL-mediated LOX-1 expression, ROS generation, and inflammation in human endothelial cells.J Vasc Surg. 2010 Nov;52(5):1290-300. doi: 10.1016/j.jvs.2010.04.085. Epub 2010 Aug 8. J Vasc Surg. 2010. PMID: 20692795
-
Colchicine inhibits the prothrombotic effects of oxLDL in human endothelial cells.Vascul Pharmacol. 2021 Apr;137:106822. doi: 10.1016/j.vph.2020.106822. Epub 2020 Nov 21. Vascul Pharmacol. 2021. PMID: 33232770
-
Arsenic augments the uptake of oxidized LDL by upregulating the expression of lectin-like oxidized LDL receptor in mouse aortic endothelial cells.Toxicol Appl Pharmacol. 2013 Dec 15;273(3):651-8. doi: 10.1016/j.taap.2013.10.012. Epub 2013 Oct 19. Toxicol Appl Pharmacol. 2013. PMID: 24145059
-
Lectin-like oxidized low density lipoprotein receptor 1 (LOX-1) in atherogenesis: a brief review.Curr Med Chem. 2009;16(21):2641-52. doi: 10.2174/092986709788681994. Curr Med Chem. 2009. PMID: 19601801 Review.
-
Upregulated LOX-1 Receptor: Key Player of the Pathogenesis of Atherosclerosis.Curr Atheroscler Rep. 2019 Jul 27;21(10):38. doi: 10.1007/s11883-019-0801-y. Curr Atheroscler Rep. 2019. PMID: 31350594 Review.
Cited by
-
Relationship between lipoproteins, thrombosis, and atrial fibrillation.Cardiovasc Res. 2022 Feb 21;118(3):716-731. doi: 10.1093/cvr/cvab017. Cardiovasc Res. 2022. PMID: 33483737 Free PMC article. Review.
-
Mitochondrial Dysfunction and DNA Damage in the Context of Pathogenesis of Atherosclerosis.Biomedicines. 2020 Jun 18;8(6):166. doi: 10.3390/biomedicines8060166. Biomedicines. 2020. PMID: 32570831 Free PMC article. Review.
-
Effects of PCSK-9 Inhibition by Alirocumab Treatments on Biliary Cirrhotic Rats.Int J Mol Sci. 2022 Jul 2;23(13):7378. doi: 10.3390/ijms23137378. Int J Mol Sci. 2022. PMID: 35806383 Free PMC article.
-
Colchicine in Athero-Thrombosis: Molecular Mechanisms and Clinical Evidence.Int J Mol Sci. 2023 Jan 27;24(3):2483. doi: 10.3390/ijms24032483. Int J Mol Sci. 2023. PMID: 36768804 Free PMC article. Review.
-
CD8+ T Cells in Atherosclerosis.Cells. 2020 Dec 29;10(1):37. doi: 10.3390/cells10010037. Cells. 2020. PMID: 33383733 Free PMC article. Review.
Publication types
MeSH terms
Substances
LinkOut - more resources
Full Text Sources
Medical
Research Materials
Miscellaneous